These findings of our study suggest that the somatic CDH1 mutations and FGFR2 copy number gains may play an important role in gastric cancer development, while their higher frequencies in younger patients may contribute to worsening prognosis consequences. The gene discussed is CDH1; the disease is gastric cancer.